Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series

被引：92

作者：

Kenny, Patrick R. ^{[1
]}

Brady, Daniel E. ^{[1
]}

Torres, Dawn M. ^{[1
]}

Ragozzino, Linda ^{[2
]}

Chalasani, Naga ^{[2
]}

Harrison, Stephen A. ^{[1
]}

机构：

[1] San Antonio Uniformed Serv Hlth Consortium, Dept Gastroenterol, San Antonio, TX USA

[2] Indiana Univ, Sch Med, Indianapolis, IN USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷 / 12期

关键词：

EXENDIN-4; GLUCOSE; MELLITUS; THERAPY; WEIGHT; TRIAL; MICE;

D O I：

10.1038/ajg.2010.363

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：2707 / 2709

页数：4

共 11 条

[1] Ahmad SR, 2008, NEW ENGL J MED, V358, P1970
[2] EXENATIDE-INDUCED ACUTE PANCREATITIS
Ayoub, Walaa A.
Kumar, Ashok A.
Naguib, Hossam S.
Taylor, Harris C.
[J]. ENDOCRINE PRACTICE, 2010, 16 (01) : 80 - 83
[3] Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
Gallwitz, Baptist
[J]. DRUG SAFETY, 2010, 33 (02) : 87 - 100
[4] Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations
Greig, NH
Holloway, HW
De Ore, KA
Jani, D
Wang, Y
Zhou, J
Garant, MJ
Egan, JM
[J]. DIABETOLOGIA, 1999, 42 (01) : 45 - 50
[5] Orlistat for Overweight Subjects with Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial
Harrison, Stephen A.
Fecht, Will
Brunt, Elizabeth M.
Neuschwander-Tetri, Brent A.
[J]. HEPATOLOGY, 2009, 49 (01) : 80 - 86
[6] Synthetic exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
Kolterman, OG
Buse, JB
Fineman, MS
Gaines, E
Heintz, S
Bicsak, TA
Taylor, K
Kim, D
Aisporna, M
Wang, Y
Baron, AD
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) : 3082 - 3089
[7] Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Promrat, Kittichai
Kleiner, David E.
Niemeier, Heather M.
Jackvony, Elizabeth
Kearns, Marie
Wands, Jack R.
Fava, Joseph L.
Wing, Rena R.
[J]. HEPATOLOGY, 2010, 51 (01) : 121 - 129
[8] Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
Ratner, R. E.
Maggs, D.
Nielsen, L. L.
Stonehouse, A. H.
Poon, T.
Zhang, B.
Bicsak, T. A.
Brodows, R. G.
Kim, D. D.
[J]. DIABETES OBESITY & METABOLISM, 2006, 8 (04) : 419 - 428
[9] Shields William W, 2009, Therap Adv Gastroenterol, V2, P157, DOI 10.1177/1756283X09105462
[10] Incretin mimetics as a novel therapeutic option for hepatic steatosis
Tushuizen, Maarten E.
Bunck, Mathijs C.
Pouwels, Petra J.
van Waesberghe, Jan Hein T.
Diamant, Michaela
Heine, Robert J.
[J]. LIVER INTERNATIONAL, 2006, 26 (08) : 1015 - 1017

← 1 2 →